MeiraGTx

Vertically integrated, clinical-stage gene therapy company developing transformative treatments for severe diseases using proprietary AAV gene therapy platform, with a focus on inherited retinal diseases and other rare conditions.

Location
New York, New York, USA
Founded
2015
Investors
1
Categories
gene-therapy, ophthalmology, rare-disease, biotech, aav

Investors

NameLocationTypeStagesPortfolio
AlbionVC (Healthcare)London, UKbiotech-focused
seedseries-a+1
17